跳至主要内容
临床试验/CTRI/2014/08/004918
CTRI/2014/08/004918已完成4 期

A Phase IV, Monocentric, Open Label, Clinical Study to Evaluate the Efficacy and Safety of AphtoFix® Mouth Ulcer Cream Manufactured by Bonyf AG in Subjects Sufferingfrom Mouth Ulcer.

Bonyf AG0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male or female subjects with 18 â?? 65 years of age (both
  • inclusive).
  • 2. Subjects having mouth ulcer size >2 mm in locations for easily
  • accessible for evaluation and treatment.
  • 3. Subject with time of onset of mouth ulceration within 48 hours.
  • 4. Subject who agreed, not to use any other medication to treat
  • mouth ulcer during study period.
  • 5. Subject willingness to comply with the study schedule and
  • procedures.
  • 6. Subject / legally acceptable representative (LAR) of subject
  • willing to sign and date written informed consent to participate
  • in the study. However, if the subject/LAR of subject is illiterate,
  • the impartial witness would sign the ICF.

排除标准

  • 1. Subjects with a history of allergy for content present in
  • 2. Subjects with any invasive dental procedures within 2 weeks
  • prior to screening visit.
  • 3. History of uncontrolled chronic disease (e.g. chronic liver
  • disease, chronic renal disease)
  • 4. Use of any other medication to treat mouth ulcer in current
  • 5. Participation in any other clinical study during last 30 days.
  • 6. Subject with any condition which in the opinion of the
  • investigator makes the subject unsuitable for inclusion.
  • 7. Subject is a female who is pregnant or willing to get pregnant,
  • not ready to use contraceptive measures during the trial period,
  • or is breast feeding.

研究者

发起方
Bonyf AG

相似试验